Rate this post

Dr. House vs BMI MD: Compare GLP-1 Programs & Pricing

Side-by-side Dr. House and BMI MD: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

Dr. House and BMI MD are two established telehealth providers offering GLP-1–based weight management programs. This article compares Dr. House vs BMI MD to help you identify which best fits your goals and preferences.

Visit Dr. House
Explore BMI MD

Dr. House vs BMI MD: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
Dr. House	Not publicly listed	Not publicly listed	Not listed (Code: N/A)	No membership required
BMI MD	Not publicly listed	Not publicly listed	Not listed (Code: N/A)	Not publicly listed

Dr. House vs BMI MD: Medical Process & Accessibility

Dr. House focuses on fast telehealth intake and clinician review to determine eligibility for GLP-1 therapy. The platform typically collects medical history, current medications, and relevant labs or vitals, and a licensed clinician makes the prescribing decision. BMI MD similarly uses telemedicine intake forms and clinician evaluation but advertises more structured follow-up and dose optimization in some plans. Both providers operate under U.S. telehealth regulations and require clinicians to assess suitability and contraindications (for example, pregnancy, pancreatitis history, or med interactions) before prescribing.

Start with Dr. House

Dr. House vs BMI MD: Pricing Comparison

Neither provider publishes fixed, nationwide starting prices for compounded semaglutide or tirzepatide on their public pages at the time of writing. Pricing frequently varies by formulation, dosing schedule, pharmacy partner, and shipping. Because costs change and may include clinician fees, pharmacy dispensing, and optional coaching, we recommend contacting each provider directly for an up-to-date total cost estimate.

Compare BMI MD Pricing

Where providers do list promotions or codes, those offers can reduce first-month costs. In this comparison both Dr. House and BMI MD did not list active promo codes on their public listings; if you see a promo, verify its terms, expiration, and whether it applies to compounded medications or branded prescriptions. Always confirm any promotional pricing with the provider’s enrollment team.

Dr. House vs BMI MD: Clinical Oversight & Support

Both platforms connect patients with licensed clinicians who evaluate medical history, assess contraindications, and monitor for adverse effects. Standard-of-care telehealth practice requires clinicians to discuss common side effects (nausea, GI upset), signs that warrant immediate attention, and a plan for dose titration and follow-up. Providers must disclose that compounded GLP-1 products are not FDA-approved branded formulations and should be used only after clinician assessment.

Book a Consultation with Dr. House

Dr. House vs BMI MD: Medication Quality & Safety

Both providers work with licensed U.S. pharmacies to dispense compounded GLP-1 medications. Compounded semaglutide or tirzepatide are legal when prescribed by a licensed clinician, but they are not the same as branded, FDA-approved products like Wegovy® or Mounjaro®. Patients should confirm pharmacy accreditation, ask about lot testing, and ensure clinicians review allergies and relevant lab work. If you have a complex medical history, request a detailed clinical review before starting therapy.

Dr. House vs BMI MD: Customer Experience

Reported differences in user experience include speed of onboarding (often faster on platforms focused on rapid intake) versus depth of clinical follow-up (often stronger on platforms emphasizing ongoing care). Shipping times typically range from a few days to about a week after prescription approval, depending on the pharmacy and shipping option selected.

Explore BMI MD Reviews

Dr. House vs BMI MD: Final Verdict

Choose Dr. House if you prioritize straightforward, fast telehealth intake and low-friction onboarding. Choose BMI MD if you prefer more structured follow-up and a program that emphasizes dose adjustments and ongoing clinician communication. Both providers are credible telehealth options; ensure any decision is based on a clinician’s medical assessment and current pricing details directly from the provider.

Join Dr. House
Get Started with BMI MD

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Telehealth clinicians must evaluate each patient’s eligibility for GLP-1 therapy; compounded products are not identical to FDA‑approved branded medications. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice